Suchergebnisse - "Lee, Hang"

PubPharm (20)

1

Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer

enthalten in: Gynecologic oncology | 2021

von Krasner, C. | Campos, S. | Young, C. | +8

2

A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer

enthalten in: Gynecologic oncology | 2014

von Viswanathan, A. | Lee, H. | Berkowitz, R. | +7

3

A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer

enthalten in: Gynecologic oncology | 2014

von Viswanathan, A. | Lee, H. | Berkowitz, R. | +7

4

Sequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancer

enthalten in: Gynecologic oncology | 2012

von Matulonis, U. | Pereira, L. | Liu, J. | +7

5

Sequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancer

enthalten in: Gynecologic oncology | 2012

von Matulonis, U. | Pereira, L. | Liu, J. | +7

6

Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors

enthalten in: Gynecologic oncology | 2010

von Roche, M. | Rudd, P. | Krasner, C. | +7

7

Targeted therapy in gynecologic oncology: Biology, strategy, and assessment

enthalten in: Gynecologic oncology | 2010

von Roche, M. | Rudd, P. | Krasner, C. | +7

8

Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma

enthalten in: Gynecologic oncology | 2009

von Liu, J. | Hirsch, M. | Lee, H. | +1

9

Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma

enthalten in: Gynecologic oncology | 2009

von Liu, J. | Hirsch, M. | Lee, H. | +1

10

Comparison of the quality of life of early and advanced stage ovarian cancer survivors

enthalten in: Gynecologic oncology | 2009

von Mirabeau-Beale, K. | Kornblith, A. | Penson, R. | +7